Evidence map›Paper›PMID 40808304›Full record

ArticleNucleic acids research2025

Cell sorting based on single nucleotide variation enables characterization of mutation-dependent transcriptome and chromatin states.

Roberto Salatino, Marianna Franco, Arantxa Romero-Toledo, Ebba K Blomqvist, Yi Wang, Shanel Tsuda, James M Burke, Oszkar Szentirmai, Michalina Janiszewska

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Roberto SalatinoDepartment of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Marianna FrancoDepartment of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Arantxa Romero-ToledoDepartment of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Ebba K BlomqvistDepartment of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Yi WangDepartment of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Shanel TsudaDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
James M BurkeDepartment of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Oszkar SzentirmaiCenter for Neurological Surgery and Neurosciences, Cleveland Clinic Martin Health, Port St. Lucie, FL 34994, United States.
Michalina JaniszewskaDepartment of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.ORCID 0000-0002-8592-5146

Funding

Understanding the OAS/RNase L pathway during pathogenic viral infectionsR35GM151249 · NIGMS · UNIVERSITY OF FLORIDA · PI James M Burke · 2023 to 2026
$1.9M
Florida Center for Brain Tumor Research SeedHerbert Wertheim University of Florida Scripps Institute for Biomedical Innovation and TechnologyNIGMS NIH HHS R35 GM151249NIH HHS K99/R00 CA201606NIH HHS R35GM151249Scripps Research Institute
6 · The paper itself

Abstract

Point mutations in oncogenes and tumor suppressor genes are common drivers of tumorigenesis. Moreover, single nucleotide variants (SNVs) also contribute to cancer by altering the noncoding regions of the genome. However, connecting SNVs to transcriptomic and epigenetic changes at the single-cell level remains challenging. To enable studies of rare populations of cells harboring specific point mutations, we developed STAR-FACS [Specific-To-Allele polymerase chain reaction (PCR) - fluorescence-activated cell sorting (FACS)]. This method allows for cell labeling based exclusively on genomic allele alteration, by in-cell DNA amplification. Labeled cells are then sorted and profiled with bulk or single cell transcriptomics. The labeling method is also compatible with downstream characterization of chromatin features with CUT&Tag (Cleavage Under Targets and Tagmentation). Our proof-of-principle study shows that STAR-FACS can be used to separate cells based on TERT promoter mutation status and is applicable to primary cell lines and dissociated solid tumor tissue. We demonstrate that glioblastoma cell lines derived from the same tumor but harboring distinct TERT promoter SNVs have different transcriptional programs. STAR-FACS provides a novel tool for studies linking subclonal noncoding SNVs with transcriptomic and epigenetic heterogeneity.

Indexed as

ChromatinFlow CytometryPolymorphism, Single NucleotideTranscriptomeCell Line, TumorGlioblastomaHumansPoint MutationPromoter Regions, GeneticSingle-Cell AnalysisTelomeraseChromatinTelomeraseTERT protein, human

Identifiers

PMID40808304
PMCPMC12350099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.